Boxer Asset Management amends Tyra Biosciences stake

TL;DR

Boxer Asset Management updated their Tyra Biosciences filing on 10/15/24. Watch this space.

AI Summary

Boxer Asset Management Inc. has amended its Schedule 13D filing for Tyra Biosciences, Inc. on October 15, 2024. The filing indicates a change in beneficial ownership of Tyra Biosciences' common stock. Boxer Asset Management Inc. is the entity making the filing, with Josh La Grange of Fried, Frank, Harris, Shriver & Jacobson LLP listed as the authorized contact.

Why It Matters

This amendment signals a potential shift in major shareholder activity for Tyra Biosciences, which could influence stock price and corporate strategy.

Risk Assessment

Risk Level: medium — Schedule 13D filings often precede significant corporate actions or shifts in control, which can introduce volatility.

Key Numbers

• 20241015 — Filing Date (Date of the amended filing)
• 20241010 — Event Date (Date of event requiring filing)

Key Players & Entities

• Boxer Asset Management Inc. (company) — Filing entity
• Tyra Biosciences, Inc. (company) — Subject company
• Josh La Grange (person) — Authorized contact
• Fried, Frank, Harris, Shriver & Jacobson LLP (company) — Legal counsel

FAQ

Key Financial Figures

• $0.0001 — , Inc. (Name of Issuer) Common Stock, $0.0001 par value per share (Title of Class of
• $5 million — to three years of probation, a fine of $5 million and a special assessment of $300. Sepa
• $300 — $5 million and a special assessment of $300. Separately, on April 3, 2024, Mr. Lew
• $1,636,645.11 — Lewis agreed to pay a civil penalty of $1,636,645.11 and agreed to be permanently enjoined b

Filing Documents

• ff3991156_13da3-tyra.htm (SC 13D/A) — 99KB
• 0000895345-24-000423.txt ( ) — 100KB

is hereby amended and restated to read as follows

Item 2 is hereby amended and restated to read as follows: This Schedule 13D is jointly filed by Boxer Management and Mr. Lewis. Boxer Management, a Bahamian international business company, is the managing member and majority owner of Boxer Capital, a limited liability company organized under the laws of Delaware. Mr. Lewis is the sole indirect owner of and controls Boxer Management. Boxer Management is primarily engaged in the business of investing in securities. Mr. Lewis is a citizen of the United Kingdom and his present principal occupation or employment is engaging in business as a private investor including through the investments of Boxer Capital. The address of each of Boxer Management and Mr. Lewis for purposes of this filing is: Albany Financial Center, Suite 207, Lewis Drive, N7776, New Providence, Bahamas. Set forth on Schedule A , and incorporated herein by reference, is the (a) name, (b) residence or business address, (c) present principal occupation or employment and (d) citizenship, of each executive officer and director of Boxer Management and (e) name of any corporation or other organization in which such occupation or employment is conducted, together with the principal business and address of any such corporation or organization other than Boxer Management. Except as set forth on Schedule B to this Schedule 13D, none of the Reporting Persons nor any of the individuals identified on Schedule A to this Schedule 13D has, during the past five years, (a) been convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors), or (b) been a party to a civil proceeding of a judicial or administrative body of competent jurisdiction and as a result of such proceeding was or is subject to a judgment, decree or final order enjoining future violations of, or prohibiting, or mandating activities subject to, federal or state securities laws or a finding of any violation with respect to such laws. Item 3. Source and Amount of Funds

is hereby amended by the addition of the following

Item 3 is hereby amended by the addition of the following: The disclosure set forth below in Item 4 is hereby incorporated herein. Item 4. Purpose of Transaction.

is hereby amended by the addition of the following

Item 4 is hereby amended by the addition of the following: On October 10, 2024, Boxer Management, Boxer Capital and BCM entered into the IMA, pursuant to which Boxer Capital has delegated exclusive voting and investment power over its investment portfolio to BCM. Consequently, BCM has acquired beneficial ownership of the shares of Common Stock held by Boxer Capital and, without reflecting any change in its economic interest in such securities, Boxer Capital has thereby ceased to beneficially own the securities held in its investment portfolio, including shares of Common Stock. Consequently, each of Boxer Management and Mr. Lewis has ceased to beneficially own the securities held in Boxer Capital's investment portfolio. Item 5. Interest in Securities of the Issuer.

is hereby amended and restated to read as follows

Item 5 is hereby amended and restated to read as follows: All percentages are based on 52,806,137 shares of the Issuer's Common Stock outstanding as of August 5, 2024 as set forth in the Issuer's 10-Q filed with the Securities and Exchange Commission on August 7, 2024. (a) The Reporting Persons beneficially own no shares of Common Stock. (b) The Reporting Persons have no rights or powers to vote, or to direct the vote of, or to dispose of, or to direct the disposition of, shares of the Common Stock. (c) Other than as described herein in Item 4 or transactions previously reported on Form 4, the Reporting Persons have not engaged in any transactions in the Common Stock in the past 60 days. (d) Not applicable. (e) As described in Item 4, as of October 10, 2024, Boxer Management and Mr. Lewis ceased to beneficially own more than 5% of the outstanding shares of Common Stock. Item 7. Material to be Filed as Exhibits.

is hereby amended by the addition of the following

Item 7 is hereby amended by the addition of the following: Exhibit No. Description Exhibit 3 Joint Filing Agreement, dated October 15, 2024, among Boxer Management and Mr. Lewis.

SIGNATURES

SIGNATURES After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this Dated: October 15, 2024 BOXER ASSET MANAGEMENT INC. By: /s/ Paul Higgs Name: Paul Higgs Title: Director JOSEPH C. LEWIS /s/ Joseph C. Lewis Joseph C. Lewis, Individually JOINT FILING AGREEMENT PURSUANT TO RULE 13d-1(k) In accordance with Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them of a Statement on Schedule 13D and any amendments to it with respect to Common Stock, $0.0001 par value per share, of Tyra Biosciences, Inc. and further agree that this Joint Filing Agreement be included as an Exhibit to those joint filings. Each of the undersigned agrees to be responsible for the timely filing of the Schedule 13D and any amendments thereto, and for the completeness and accuracy of the information concerning itself contained therein. This agreement may be executed in any number of counterparts, all of which taken together shall constitute one and the same instrument. Dated: October 15, 2024. BOXER ASSET MANAGEMENT INC. By: /s/ Paul Higgs Name: Paul Higgs Title: Director JOSEPH C. LEWIS /s/ Joseph C. Lewis Joseph C. Lewis, Individually SCHEDULE A ADDITIONAL INFORMATION CONCERNING THE REPORTING PERSONS BOXER ASSET MANAGEMENT INC. The executive officers and directors of Boxer Asset Management Inc. are set forth below. Each individual's business address is Albany Financial Center, Suite 207, Lewis Drive, N7776, New Providence, Bahamas. Except as otherwise stated, the present principal occupation or employment set forth below opposite the name of each person refers to employment with Boxer Asset Management Inc. Name Present Principal Occupation or Employment Citizenship Joe Lewis Director, President United Kingdom Paul Higgs Director, Vice President United States SCHEDU

View Full Filing

View this SC 13D/A filing on SEC EDGAR